Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Hospital Frankfurt, Frankfurt, Germany.
Institute of Transfusion Medicine and Immunohematology, Department of Transplantation Immunology and Immunogenetics, University Hospital Frankfurt, Frankfurt, Germany.
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1907-1916. doi: 10.1210/jc.2018-01621.
Autoimmune endocrinopathies result from environmental triggers on the genetic background of risk alleles, especially HLA-DR and HLA-DQ with alanine (Ala) in HLA-DQB1 position 57 (Ala57), whereas amino acid Asp57 is protective.
Differentiate the effects of HLA-DQB1 amino acid variants at position 57 in adult patients with isolated endocrinopathies and autoimmune polyglandular syndrome type 2 (APS-2) compared with healthy controls in relation to gender.
University Hospital Frankfurt, Frankfurt, Germany.
Two hundred seventy-eight patients with APS-2 and 1373 patients with isolated endocrinopathies: [type 1 diabetes (T1D), n = 867], Addison disease (AD, n = 185), autoimmune thyroiditis (AIT, n = 321) and 526 healthy controls.
Homozygous HLA-DQB1 Ala57 was more frequent in polyglandular T1D/AIT (OR 11.7, Pc = 3 × 10-7) and AD/AIT (OR 4.0, Pc = 3 × 10-7), as well as in isolated T1D (OR 9.7, Pc = 3 × 10-7) and AD (OR 3.1, Pc = 3 × 10-7). Heterozygous HLA-DQB1 57 Ala/non-Ala was increased in women with isolated AD and polyglandular AD/AIT (both OR 1.7, Pc= 0.02) whereas the same amino acid variant was overrepresented in men with T1D compared with women (OR 1.6, Pc = 0.004). The amino acid Ala57 was more frequent (OR 2.0, Pc = 0.02) and the amino acid Asp57 was much more rare (OR 0.4, Pc = 0.007) in the APS-2 cohort T1D/AIT than in AD/AIT.
HLA-DQB1 confers strong susceptibility by Ala57 homozygosity and protection by non-Ala57, both in adult isolated and polyglandular diseases. Frequencies of HLA-DQB1 amino acids differentiate between APS-2 T1D/AIT and AD/AIT. HLA-DQB1 Ala57 heterozygous women are at increased risk for AD or AIT, whereas men were found to have an increased susceptibility for T1D.
自身免疫性内分泌疾病是由环境触发因素在风险等位基因的遗传背景下引起的,特别是 HLA-DR 和 HLA-DQ 上的丙氨酸(Ala)位置 57(Ala57),而天冬氨酸(Asp)57 是保护性的。
与健康对照组相比,在成年单纯内分泌疾病和自身免疫性多腺体综合征 2 型(APS-2)患者中,区分 HLA-DQB1 氨基酸变体在位置 57 上的影响,该位置与性别有关。
德国法兰克福大学医院。
278 例 APS-2 患者和 1373 例单纯内分泌疾病患者:[1 型糖尿病(T1D),n=867]、艾迪生病(AD),n=185)、自身免疫性甲状腺炎(AIT),n=321)和 526 名健康对照者。
多腺体 T1D/AIT(OR 11.7,Pc=3×10-7)和 AD/AIT(OR 4.0,Pc=3×10-7)以及孤立性 T1D(OR 9.7,Pc=3×10-7)和 AD(OR 3.1,Pc=3×10-7)中 HLA-DQB1Ala57 纯合子更为常见。HLA-DQB157Ala/非-Ala 杂合子在孤立性 AD 和多腺体 AD/AIT 女性中增加(两者 OR 1.7,Pc=0.02),而相同的氨基酸变体在 T1D 男性中比女性更为常见(OR 1.6,Pc=0.004)。与 AD/AIT 相比,APS-2 队列 T1D/AIT 中氨基酸 Ala57 更为常见(OR 2.0,Pc=0.02),而氨基酸 Asp57 则罕见得多(OR 0.4,Pc=0.007)。
HLA-DQB1 通过 Ala57 纯合子赋予强烈的易感性,并通过非-Ala57 赋予保护作用,无论是在成人单纯性和多腺体疾病中。HLA-DQB1 氨基酸的频率可区分 APS-2 T1D/AIT 和 AD/AIT。HLA-DQB1Ala57 杂合子女性患 AD 或 AIT 的风险增加,而男性患 T1D 的易感性增加。